Skip to content
10-Q

Quarterly Report

BIO-TECHNE Corp TECH

0001104659-25-107053

← back to feed
Filed
Nov 5, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Oct 30, 2025 155.81M sh
Shares Diluted Q1 2026 · Sep 30, 2025 156.36M sh
Shares Diluted Q1 2026 · Sep 30, 2024 161.12M sh
Stock Repurchased Q1 2026 · Sep 30, 2025 $24K
Dividends Paid Q1 2026 · Sep 30, 2025 $12.44M
Dividends Paid Q1 2026 · Sep 30, 2024 $12.69M
Capex Q1 2026 · Sep 30, 2025 $5.36M
Capex Q1 2026 · Sep 30, 2024 $9.17M
Operating Cash Flow Q1 2026 · Sep 30, 2025 $27.59M
Operating Cash Flow Q1 2026 · Sep 30, 2024 $63.89M
Cash And Equivalents Q1 2026 · Sep 30, 2025 $144.96M
Cash And Equivalents Q1 2026 · Jun 30, 2025 $162.19M
Current Liabilities Q1 2026 · Sep 30, 2025 $144.55M
Current Liabilities Q1 2026 · Jun 30, 2025 $175.85M
Current Assets Q1 2026 · Sep 30, 2025 $609.51M
Current Assets Q1 2026 · Jun 30, 2025 $608.3M
Total Assets Q1 2026 · Sep 30, 2025 $2.53B
Total Assets Q1 2026 · Jun 30, 2025 $2.56B
Eps Diluted Q1 2026 · Sep 30, 2025 $0.24
Eps Diluted Q1 2026 · Sep 30, 2024 $0.21
Eps Basic Q1 2026 · Sep 30, 2025 $0.25
Eps Basic Q1 2026 · Sep 30, 2024 $0.21
Sga Expense Q1 2026 · Sep 30, 2025 $116.21M
Sga Expense Q1 2026 · Sep 30, 2024 $119.16M
Net Income Q1 2026 · Sep 30, 2025 $38.19M
Net Income Q1 2026 · Sep 30, 2024 $33.6M
Operating Income Q1 2026 · Sep 30, 2025 $47.66M
Operating Income Q1 2026 · Sep 30, 2024 $39.99M
Gross Profit Q1 2026 · Sep 30, 2025 $188.11M
Gross Profit Q1 2026 · Sep 30, 2024 $183.02M
Cost Of Revenue Q1 2026 · Sep 30, 2025 $98.44M
Cost Of Revenue Q1 2026 · Sep 30, 2024 $106.44M
Revenue Q1 2026 · Sep 30, 2025 $286.56M
Revenue Q1 2026 · Sep 30, 2024 $289.46M